India, July 7 -- Revolution Medicines Inc. (RVMD), a late-stage clinical oncology company, on Tuesday announced the expedited phased review of Daraxonrasib in treating pancreatic ductal cancer by the ... Read More
India, July 7 -- DigitalOcean Holdings, Inc. (DOCN) shares rose 7.28 percent to $140.93, gaining $9.56 on Tuesday, from the previous close of $131.37, after the cloud infrastructure provider announced... Read More
India, July 7 -- Tuesday, Deutsche Post AG (DPSTF.PK) announced preliminary results for the second quarter, reporting revenue growth and positive earnings momentum, especially in the DHL Express divis... Read More
India, July 7 -- A report released by the Commerce Department on Tuesday showed a substantial increase in the size of the U.S. trade deficit in the month of May. The Commerce Department said the trad... Read More
India, July 7 -- Alamar Biosciences, Inc. (ALMR), a commercial-stage proteomics company, announced on Tuesday the commercial launch of a multiplexed blood-based immunoassay for eMTBR-Tau, a biomarker ... Read More
India, July 7 -- Stocks have moved mostly lower during trading on Tuesday, giving back ground following the strength seen in the previous session. The major averages have all moved to the downside, wi... Read More
India, July 7 -- Rivian Automotive, Inc. (RIVN) stock fell 13.20 percent to $17.48, down $2.66 on Tuesday, from its previous close of $20.14, possibly after the electric vehicle maker announced a publ... Read More
India, July 7 -- Tuesday, Sompo Holdings, Inc. (SMPNY.PK) announced an agreement to acquire Service Insurance Companies, a specialist in workers' compensation insurance. The financial terms of the dea... Read More
India, July 7 -- Alterity Therapeutics Ltd. (ATHE), a clinical-stage biotechnology company, announced that it has received the U.S. Food and Drug Administration's meeting minutes from the End-of Phase... Read More
India, July 7 -- Agios Pharmaceuticals Inc. (AGIO), a commercial-stage biopharmaceutical company, on Tuesday announced that the U.S. Food and Drug Administration (FDA) has accepted under a priority re... Read More